AAV9-dominant-negative SUN1 miniprotein
AAV9-dominant-negative SUN1 miniprotein has been studied in 1 paper since 2021: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Aug 5, 2021: “Disrupting the LINC complex by AAV mediated gene transduction prevents progression of Lamin induced cardiomyopathy”.
1 paper studies it2 findingsUpdated
See all 1 papers on AAV9-dominant-negative SUN1 miniprotein
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Institute of Molecular and Cell Biology and 1 more
- 2 of 2 findings with company ties
- Animals1
What did studies of AAV9-dominant-negative SUN1 miniprotein find?
2Studies of AAV9-dominant-negative SUN1 miniprotein measured 2 outcomes: dilated cardiomyopathy and lifespan.
Dilated cardiomyopathy
downin mice1
1 study
Dilated cardiomyopathy
downin mice1
AAV9-dominant-negative SUN1 miniprotein prevents dilated cardiomyopathy in Lmna mutant mice.
“Cardiomyocyte-specific expression of the SUN1 miniprotein prevents cardiomyopathy progression”
Animalsin Lmna mutant mice
Nature communications
Lifespan
upin mice1
1 study
Lifespan
upin mice1
AAV9-dominant-negative SUN1 miniprotein extends lifespan in Lmna deficient cardiomyocytes in mice (at least a fivefold extension in lifespan).
“displacing the cardiomyocyte KASH complexes from the nuclear periphery, resulting in at least a fivefold extension in lifespan.”
Animalsin Lmna deficient cardiomyocytes in mice
Nature communications